Literature DB >> 11048947

Cartilage degradation by stimulated human neutrophils: reactive oxygen species decrease markedly the activity of proteolytic enzymes.

J Schiller1, S Benard, S Reichl, J Arnhold, K Arnold.   

Abstract

BACKGROUND: Although neutrophilic granulocytes clearly contribute to cartilage degradation in rheumatic diseases, it is unclear if reactive oxygen species (ROS) or proteolytic enzymes are the most important components in cartilage degradation and how they interact.
RESULTS: Neutrophils were stimulated by chemicals conferring a different degree of ROS formation and enzyme release. Supernatants of neutrophils were incubated with thin slices of pig articular cartilage. Supernatants of cartilage were assayed by NMR spectroscopy, MALDI-TOF mass spectrometry and relevant biochemical methods. Stimulation conditions of neutrophils correlated well with the extent of cartilage degradation. Due to the release of different enzymes, cartilage degradation could be best monitored by NMR since mainly low-mass degradation products were formed. Astonishingly, the suppression of the formation of ROS resulted in decreased cartilage degradation.
CONCLUSION: ROS formed by neutrophils are not directly involved in cartilage degradation but influence the activity of proteolytic enzymes, which are the main effectors of cartilage degradation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11048947     DOI: 10.1016/s1074-5521(00)00013-2

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  9 in total

1.  Lysophosphatidylcholines to phosphatidylcholines ratio predicts advanced knee osteoarthritis.

Authors:  Weidong Zhang; Guang Sun; Dawn Aitken; Sergei Likhodii; Ming Liu; Glynn Martin; Andrew Furey; Edward Randell; Proton Rahman; Graeme Jones; Guangju Zhai
Journal:  Rheumatology (Oxford)       Date:  2016-05-09       Impact factor: 7.580

2.  1H and 13C HR-MAS NMR investigations on native and enzymatically digested bovine nasal cartilage.

Authors:  J Schiller; L Naji; D Huster; J Kaufmann; K Arnold
Journal:  MAGMA       Date:  2001-08       Impact factor: 2.310

Review 3.  Understanding the major risk factors in the beginning and the progression of rheumatoid arthritis: current scenario and future prospects.

Authors:  Mahendra Kumar Verma; Kota Sobha
Journal:  Inflamm Res       Date:  2015-07-07       Impact factor: 4.575

Review 4.  Therapeutic targeting of neutrophil exocytosis.

Authors:  Sergio D Catz; Kenneth R McLeish
Journal:  J Leukoc Biol       Date:  2020-01-28       Impact factor: 4.962

5.  Pulsed gradient stimulated echo (PGStE) NMR shows spatial dependence of fluid diffusion in human stage IV osteoarthritic cartilage.

Authors:  Sarah E Mailhiot; Sarah L Codd; Jennifer R Brown; Joseph D Seymour; Ronald K June
Journal:  Magn Reson Med       Date:  2018-02-02       Impact factor: 4.668

6.  Reassessment of the microbicidal activity of reactive oxygen species and hypochlorous acid with reference to the phagocytic vacuole of the neutrophil granulocyte.

Authors:  Emer P Reeves; Markus Nagl; Jasminca Godovac-Zimmermann; Anthony W Segal
Journal:  J Med Microbiol       Date:  2003-08       Impact factor: 2.472

Review 7.  Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy.

Authors:  Nitya Nair; Henrik E Mei; Shih-Yu Chen; Matthew Hale; Garry P Nolan; Holden T Maecker; Mark Genovese; C Garrison Fathman; Chan C Whiting
Journal:  Arthritis Res Ther       Date:  2015-05-18       Impact factor: 5.156

Review 8.  Chlorinated Phospholipids and Fatty Acids: (Patho)physiological Relevance, Potential Toxicity, and Analysis of Lipid Chlorohydrins.

Authors:  Jenny Schröter; Jürgen Schiller
Journal:  Oxid Med Cell Longev       Date:  2016-12-20       Impact factor: 6.543

Review 9.  Fcγ and Complement Receptors and Complement Proteins in Neutrophil Activation in Rheumatoid Arthritis: Contribution to Pathogenesis and Progression and Modulation by Natural Products.

Authors:  Adriana Balbina Paoliello-Paschoalato; Larissa Fávaro Marchi; Micássio Fernandes de Andrade; Luciana Mariko Kabeya; Eduardo Antônio Donadi; Yara Maria Lucisano-Valim
Journal:  Evid Based Complement Alternat Med       Date:  2015-08-05       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.